Cytosorbents Corp
CTSO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001175151
In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Cytosorbents Corp changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 59 | 1 | 58 | 0 |
| Shares | 15.2M | 37 | 15.2M | +18.2K (+0.1%) |
| Value | $51.3M | $125 | $54.7M | +$3.31M (+6.4%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Cytosorbents Corp at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Houlihan Financial Resource Group, Ltd. | 18,600 | $59.0K | 0.00% |
| Resources Investment Advisors, LLC. | 15,000 | $53.9K | 0.00% |
| AE Wealth Management LLC | 13,783 | $49.5K | 0.00% |
| B.O.S.S. Retirement Advisors, LLC | 13,491 | $48.4K | 0.01% |
| Acadian Asset Management LLC | 9,059 | $32.0K | 0.00% |
| Harbor Capital Advisors, Inc. | 6,482 | $23.3K | 0.00% |
| Rhumbline Advisers | 1,897 | $6.81K | 0.00% |
| Tower Research Capital LLC (TRC) | 146 | $524 | 0.00% |
Sold out (8)
Institutions that held Cytosorbents Corp at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Redmile Group, LLC | 181,639 | $612.1K |
| Jane Street Group, LLC | 62,473 | $210.5K |
| Ergoteles LLC | 20,185 | $68.0K |
| Goldman Sachs Group Inc | 15,365 | $51.8K |
| Coastal Investment Advisors, Inc. | 12,000 | $40.4K |
| Squarepoint Ops LLC | 11,360 | $38.3K |
| Belvedere Trading LLC | 10,668 | $36.0K |
| Advisory Services Network, LLC | 2,200 | $7.41K |
Not filed for Q2 2023 yet (1)
Institutions that held Cytosorbents Corp at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Harvest Group Wealth Management, LLC | 37 | $125 |